
Release date: 2026-06-26 17:54:16 Article From: Lucius Laos Recommended: 7
Laos; pharmaceutical industry is relatively limited in scale, and domestic drug supply has long relied on imports of high-quality generic medicines from countries such as China and India. The pharmaceutical and medical device market in Laos is regulated by the Food and Drug Bureau. In recent years, with increased openness and favorable policies, some pharmaceutical companies have chosen to set up factories in Laos, and the countrys pharmaceutical sector has shown certain development momentum. The following are the major pharmaceutical companies currently operating in Laos.
Lucius Pharmaceuticals was established in 2020 and is located at No. 26, Thongmang Village, Xaysettha District, Vientiane, the capital of Laos. The company is a legally approved pharmaceutical manufacturer by the Lao government.
Production scale: Lucius Pharmaceuticals' factory covers an area of approximately 210,000 square meters. The company now produces over 200 generic drug varieties, covering multiple therapeutic areas. As of June 2024, Lucius Pharmaceuticals has obtained marketing approvals for 54 anticancer drugs.
Product portfolio: Lucius Pharmaceuticals focuses on antineoplastic agents as its core product line, having developed generic versions of targeted therapies including sotorasib, osimertinib, cabozantinib, larotrectinib, lorlatinib, and crizotinib. In addition, the company's products also include antihypertensive drugs such as aprocitentan.
Market presence: Lucius Pharmaceuticals has expanded its business to 12 countries, including Thailand, Indonesia, Cambodia, Vietnam, the Philippines, Singapore, Malaysia, Sri Lanka, Turkey, Japan, and China, and has established extensive partnerships.
Lao Alliance Pharmaceutical Group, founded in 2017, is a comprehensive pharmaceutical company integrating R&D, production, and sales. It occupies about 80 mu (approx. 5.3 hectares) and currently employs 243 staff. The company is one of the largest pharmaceutical enterprises in Laos and one of the three OTC drug manufacturers, holding about 27% of the Lao pharmaceutical market. Currently, the group is investing RMB 1.5 billion to build a new plant, with an expected annual output value of RMB 5 billion upon completion, which is poised to become the largest pharmaceutical factory in Southeast Asia.
The National Pharmaceutical Factory No. 2 is a state-owned pharmaceutical enterprise under the direct supervision of the Lao Ministry of Health. Established in the 1970s, it is one of the most comprehensive drug producers in Laos, with over 160 products including infusions, injections, oral tablets, oral capsules, oral syrups, ointments, and more.
In addition, Laos also has other state-owned manufacturers such as the National Pharmaceutical Factory No. 3.
Apart from the above, there are several other pharmaceutical companies in Laos, including ASEAN Food and Drug (Laos) Co., Ltd., Lao-Viet Pharmaceutical Factory, KPN Pharmaceutical Co., Ltd., and Lao Element Pharmaceutical, among others. These enterprises have all obtained official drug marketing approvals, and some of them specialize in the production of generic anticancer drugs.
Overall, the pharmaceutical industry in Laos remains in a developing stage, with a limited number of factories. However, companies like Lucius Pharmaceuticals are gradually expanding both domestic and international markets, driving the industry forward.
Laos; pharmaceutical industry is relatively limited in scale, and domestic drug supply has long relied on imports of high-quality generic medicines from countries such as China and···【more】
Recommended:8Release date: 2026-06-26
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of Laos was in the spotlight for its outstanding performance. Their booth attracted a large audience and···【more】
Recommended:613Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appointed by the World Health Organization (WHO) and director of the Microbiology Laboratory of the Nationa···【more】
Recommended:615Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensive inspection of the Lucius Pharmaceutical factory in Laos. The results of this assessment are encou···【more】
Recommended:756Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in the pharmaceutical industry, Lucius Pharmaceutical was established in Vientiane, Laos in 2020, with a···【more】
Recommended:550Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has state-of-the-art facilities, including factories designed and constructed in strict accordance with ···【more】
Recommended:782Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea, Lucius Pharmaceuticals stands on the only Turkish Strait that connects the two seas, announcing Lu···【more】
Recommended:568Release date: 2024-07-09
As we all know, from the perspective of the universe, our solar system is very small, but from the perspective of the earth, it is very huge, the edge of the solar system is the Oo···【more】
Recommended:548Release date: 2024-07-09
At the beginning of May, Lucius Pharmaceutical (Laos) Co., Ltd. officially obtained the approval of the Ministry of Health of the People's Republic of China and launched 8 prod···【more】
Recommended:561Release date: 2024-07-09
The BRAF inhibitor known as Braftovi, manufactured by the French company pierre Fabre.What is the price of Braftovi per box? Where can it be purchased?Currently, there are two main···【more】
Recommended:769Release date: 2024-07-08
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently made a technical visit to Lucius Pharmaceuticals in Laos. The purpose of the visit was to learn more ab···【more】
Recommended:714Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and mortality, which has been troubling medical workers. Clinical studies have foun···【more】
Recommended:664Release date: 2024-07-09
MONDAY, June 15, 2026 — A study published online June 8 in Nature Medicine has found that apitegromab, through its selective inhibition of myostatin, can maintain lean body mass wh···【more】
Recommended:24Release date: 2026-06-24
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combination with BCG (Bacillus Calmette-Guérin) induction and maintenance regimen has rec···【more】
Recommended:137Release date: 2026-06-01
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizumab (Keytruda, Merck & Co., Inc.) or pembrolizumab and berahyaluronidase alf···【more】
Recommended:486Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination with abiraterone acetate (brand name: Akeega, Janssen Biotech, Inc.) plus predni···【more】
Recommended:448Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubicel-onlv), the first hematopoietic stem cell transplantation (HSCT) therapy for th···【more】
Recommended:471Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (Breyanzi, developed by Juno Therapeutics, a subsidiary of Bristol Myers Squibb) ···【more】
Recommended:457Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobrutinib (Jaypirca, Eli Lilly and Company) for the treatment of adult patients with r···【more】
Recommended:512Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 study showed that for patients with HER2-positive locally advanced or metastatic ···【more】
Recommended:416Release date: 2025-12-01
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrophy (SMA), announced today its welcome for the U.S. Food and Drug Administration ···【more】
Recommended:393Release date: 2025-11-27
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued favorable opinions, proposing an amendment to the mark···【more】
Recommended:673Release date: 2025-01-13
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced solid tumors, although further prospective research is still required. Historica···【more】
Recommended:575Release date: 2025-01-06
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administration (FDA) has given the green light to the first generic version of Victoza (···【more】
Recommended:642Release date: 2024-12-30

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643